Fatime Nilüfer Yalcindag
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fatime Nilüfer Yalcindag has a total of 134 co-authors. Here are the top co-authors by number of shared publications:
- Ilknur Tugal-Tutkun
Istanbul University
6 shared publications - Pınar Çakar Özdal
Uvea Academy Eye Clinic, Ankara, Türkiye
5 shared publications - Figen Batıoğlu
Department of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey
4 shared publications - Huban Atilla
Department of Ophthalmology, Ankara University School of Medicine, Ankara, Turkey
4 shared publications - Mehmet Fatih Kağan Değirmenci
Department of Ophthalmology, Ankara Ulucanlar Eye Training and Research Hospital, Ankara, Turkey
4 shared publications - Sibel Demirel
Department of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey
4 shared publications
Latest Publications
- 21 August 2026
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 421
A visual evoked potential and optical coherence tomography cross-sectional study in patients with Behcet's disease
- 21 August 2026
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 421
A visual evoked potential and optical coherence tomography cross-sectional study in patients with Behcet's disease
- 4 July 2026
- Published by Springer Nature in Eye
- Vol. 40 (14) , 1-7
Macular serpiginous choroiditis versus macular serpiginous-like choroiditis: clinical features, outcomes and prognosis
Objective To compare the clinical characteristics, treatment outcomes, and prognostic factors of macular serpiginous choroiditis (SC) and macular serpiginous-like choroiditis (SLC). Methods This retrospective multicentre study included 30 eyes of 25 patients with macular SC or SLC. All patients underwent detailed ophthalmic evaluation, including OCT, fundus autofluorescence (FAF), and fluorescein angiography. Atrophic and hyperautofluorescent FAF areas were quantitatively assessed using ImageJ. Results Of the 30 eyes, 16 had macular SC and 14 had macular SLC. Atrophic area increased significantly in both groups but was greater in SC (2.8 ± 1.9 to 22.6 ± 8.3 mm²) than in SLC (4.1 ± 3.6 to 16.4 ± 7.0 mm²) (P < 0.001). Macular neovascularisation occurred more frequently in SC (43.7%) than SLC (7.1%) (P = 0.024). Visual outcomes were poorer in SC, with 31.2% achieving final visual acuity ≤0.1 logMAR, compared to 71.4% in SLC (P = 0. 028). All SC cases required systemic immunosuppression, versus 50% in SLC (P = 0.002), though treatment duration was longer in SLC (P = 0.007). Conclusion Macular SC exhibits more aggressive progression and worse visual prognosis than SLC. However, SLC requires prolonged immunosuppression to manage chronic inflammation.
- 4 July 2026
- Published by Springer Nature in Eye
- Vol. 40 (14) , 1-7
Macular serpiginous choroiditis versus macular serpiginous-like choroiditis: clinical features, outcomes and prognosis
Objective To compare the clinical characteristics, treatment outcomes, and prognostic factors of macular serpiginous choroiditis (SC) and macular serpiginous-like choroiditis (SLC). Methods This retrospective multicentre study included 30 eyes of 25 patients with macular SC or SLC. All patients underwent detailed ophthalmic evaluation, including OCT, fundus autofluorescence (FAF), and fluorescein angiography. Atrophic and hyperautofluorescent FAF areas were quantitatively assessed using ImageJ. Results Of the 30 eyes, 16 had macular SC and 14 had macular SLC. Atrophic area increased significantly in both groups but was greater in SC (2.8 ± 1.9 to 22.6 ± 8.3 mm²) than in SLC (4.1 ± 3.6 to 16.4 ± 7.0 mm²) (P < 0.001). Macular neovascularisation occurred more frequently in SC (43.7%) than SLC (7.1%) (P = 0.024). Visual outcomes were poorer in SC, with 31.2% achieving final visual acuity ≤0.1 logMAR, compared to 71.4% in SLC (P = 0. 028). All SC cases required systemic immunosuppression, versus 50% in SLC (P = 0.002), though treatment duration was longer in SLC (P = 0.007). Conclusion Macular SC exhibits more aggressive progression and worse visual prognosis than SLC. However, SLC requires prolonged immunosuppression to manage chronic inflammation.
- 25 May 2026
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1)
Clinical characteristics and factors associated with uveitis in juvenile idiopathic arthritis: a long-term single-center experience
Juvenile Idiopathic Arthritis uveitis (JIA-U) can progress without obvious clinical signs and cause permanent damage if left untreated, therefore early detection through regular screening is crucial for managing the disease. This study aimed to evaluate the prevalence of uveitis and factors associated with uveitis in Juvenile Idiopathic Arthritis (JIA) patients. The medical records of patients with a diagnosis of non-systemic JIA who were under the care of the Department of Paediatric Rheumatology at Ankara University between June 2010 and June 2024 were reviewed retrospectively. The demographic, clinical and laboratory characteristics of the patients were recorded and compared between those with and without uveitis. 144 patients (92 girls, 63.9%; 83 oligoarticular JIA, 57.6%) were included in the study. Uveitis was detected in 26 patients (18.1%). 12 patients (46.2%) with JIA-U experienced complications and 3 of these patients had complications at the time of JIA-U diagnosis. The group who experienced JIA-U was characterised with female sex (p = 0.048), anti-nuclear antibody (ANA) positivity (p = 0.039), younger age at the time of JIA diagnosis (p = 0.014), and more frequent articular flare-ups (p = 0.014). No significant difference was found between the groups when comparing JIA subtypes and affected joints (p > 0.05). Uveitis may present with an insidious clinical course in patients with JIA. Particularly, early onset of the disease, female gender, positive ANA status, and articular relapses should be considered warning signs for uveitis.
- 25 May 2026
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1)
Clinical characteristics and factors associated with uveitis in juvenile idiopathic arthritis: a long-term single-center experience
Juvenile Idiopathic Arthritis uveitis (JIA-U) can progress without obvious clinical signs and cause permanent damage if left untreated, therefore early detection through regular screening is crucial for managing the disease. This study aimed to evaluate the prevalence of uveitis and factors associated with uveitis in Juvenile Idiopathic Arthritis (JIA) patients. The medical records of patients with a diagnosis of non-systemic JIA who were under the care of the Department of Paediatric Rheumatology at Ankara University between June 2010 and June 2024 were reviewed retrospectively. The demographic, clinical and laboratory characteristics of the patients were recorded and compared between those with and without uveitis. 144 patients (92 girls, 63.9%; 83 oligoarticular JIA, 57.6%) were included in the study. Uveitis was detected in 26 patients (18.1%). 12 patients (46.2%) with JIA-U experienced complications and 3 of these patients had complications at the time of JIA-U diagnosis. The group who experienced JIA-U was characterised with female sex (p = 0.048), anti-nuclear antibody (ANA) positivity (p = 0.039), younger age at the time of JIA diagnosis (p = 0.014), and more frequent articular flare-ups (p = 0.014). No significant difference was found between the groups when comparing JIA subtypes and affected joints (p > 0.05). Uveitis may present with an insidious clinical course in patients with JIA. Particularly, early onset of the disease, female gender, positive ANA status, and articular relapses should be considered warning signs for uveitis.
- Open Access
- 22 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Anterior chamber inflammation grading with automatized image processing software
Anterior segment optical coherence tomography (AS-OCT) is a non-invasive imaging modality to assess anterior ocular structures at micron levels. AS-OCT image processing has been implemented in evaluating anterior chamber inflammation with differing approaches and biomarkers across studies. The primary objective of this study was to evaluate the agreement between AS-OCT–derived cell count and cell density and slit-lamp based anterior chamber cell grading using the Standardization of Uveitis Nomenclature (SUN) criteria. Secondarily, we aimed to integrate multiple AS-OCT–based biomarkers reported in prior studies into a single rule-based computational framework. We analyzed 450 images from 92 AS-OCT scans of 79 eyes (48 non-infectious, 10 infectious, 21 control) for cell count, density, morphology (area, eccentricty), aqueous-to-air relative intensity (ARI) index and anterior chamber (AC) area. Cell count and cell density were significantly different for each SUN grading score (p < 0.001). There was a significant positive correlation between the SUN grading score and ARI index (Spearman’s p < 0.001 rho = 0.410) and cell area (Spearman’s p < 0.001 rho = 0.22). Eyes with active inflammation demonstrated significantly higher ARI index (100.48[5.14] vs. 99.12[2.57] p < 0.001 r = 0.25, %95 CI [1.22, 2.71]) and eccentricity ( 0.57[0.19] vs. 0.00[0.75], p = 0.05, r = 0.11, %95 CI [0.00, 0.52]) than control eyes. No significant differences were found in cell morphology (area, eccentricity) between infectious and non-infectious uveitis. Automated AS-OCT based image processing provided a rule-based, device-specific computational framework for quantifying AC inflammation that alings with clinical grading and it may serve as a complementary tool for assessing anterior chamber inflammation in uveitis.
- 22 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessAnterior chamber inflammation grading with automatized image processing software
Anterior segment optical coherence tomography (AS-OCT) is a non-invasive imaging modality to assess anterior ocular structures at micron levels. AS-OCT image processing has been implemented in evaluating anterior chamber inflammation with differing approaches and biomarkers across studies. The primary objective of this study was to evaluate the agreement between AS-OCT–derived cell count and cell density and slit-lamp based anterior chamber cell grading using the Standardization of Uveitis Nomenclature (SUN) criteria. Secondarily, we aimed to integrate multiple AS-OCT–based biomarkers reported in prior studies into a single rule-based computational framework. We analyzed 450 images from 92 AS-OCT scans of 79 eyes (48 non-infectious, 10 infectious, 21 control) for cell count, density, morphology (area, eccentricty), aqueous-to-air relative intensity (ARI) index and anterior chamber (AC) area. Cell count and cell density were significantly different for each SUN grading score (p < 0.001). There was a significant positive correlation between the SUN grading score and ARI index (Spearman’s p < 0.001 rho = 0.410) and cell area (Spearman’s p < 0.001 rho = 0.22). Eyes with active inflammation demonstrated significantly higher ARI index (100.48[5.14] vs. 99.12[2.57] p < 0.001 r = 0.25, %95 CI [1.22, 2.71]) and eccentricity ( 0.57[0.19] vs. 0.00[0.75], p = 0.05, r = 0.11, %95 CI [0.00, 0.52]) than control eyes. No significant differences were found in cell morphology (area, eccentricity) between infectious and non-infectious uveitis. Automated AS-OCT based image processing provided a rule-based, device-specific computational framework for quantifying AC inflammation that alings with clinical grading and it may serve as a complementary tool for assessing anterior chamber inflammation in uveitis.
- 21 September 2025
- Published by Elsevier in Survey of Ophthalmology
- Vol. 71 (2) , 545-559
Clinical trials and quasi-experimental studies in the treatment of noninfectious retinal vasculitis: A systematic review from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) – Report 4
- 21 September 2025
- Published by Elsevier in Survey of Ophthalmology
- Vol. 71 (2) , 545-559
Clinical trials and quasi-experimental studies in the treatment of noninfectious retinal vasculitis: A systematic review from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) – Report 4
- 2 May 2025
- Published by Elsevier in Survey of Ophthalmology
- Vol. 70 (6) , 1144-1159
Clinical features of retinal vasculitis: A systematic review and meta‐analysis from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 3
- 2 May 2025
- Published by Elsevier in Survey of Ophthalmology
- Vol. 70 (6) , 1144-1159
Clinical features of retinal vasculitis: A systematic review and meta‐analysis from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 3
- Open Access
- 5 September 2024
- Published by Wolters Kluwer Health in Saudi Journal of Ophthalmology
- Vol. 39 (4) , 290-298
Clinical Features of Behçet’s Disease Uveitis
Behçet’s disease (BD) is a chronic, multisystemic vasculitis first described by Professor Hulusi Behçet in 1937. It is characterized by recurrent inflammatory attacks affecting multiple organs, with uveitis being a significant and severe complication that can lead to blindness. BD typically emerges between the ages of 20 and 30 years, with a higher prevalence in males and rare occurrences in children. The prevalence and severity of BD and its ocular symptoms tend to diminish with age. In Turkey, BD is a leading cause of noninfectious uveitis, and its prevalence varies across different regions. Ocular involvement, seen in up to 90% of BD patients, often appears 2–4 years after disease onset and may be the initial sign in 10%–20% of cases. BD uveitis is characterized by recurrent nongranulomatous panuveitis and retinal vasculitis, typically affecting both eyes. Diagnostic tools such as fluorescein angiography (FA), optical coherence tomography (OCT), and laser flare photometry (LFP) are essential for monitoring disease activity and guiding treatment. FA is crucial for identifying occlusive and leaky vasculitis, while OCT helps in detecting macular complications and visualizing retinal infiltrates and their sequelae. LFP quantitatively evaluates intraocular inflammation. Recognizing the ocular manifestations of BD early is vital for accurate diagnosis and effective management. This review highlights the clinical features, diagnostic tools, and importance of early diagnosis in managing BD uveitis.
- 5 September 2024
- Published by Wolters Kluwer Health in Saudi Journal of Ophthalmology
- Vol. 39 (4) , 290-298
Open AccessClinical Features of Behçet’s Disease Uveitis
Behçet’s disease (BD) is a chronic, multisystemic vasculitis first described by Professor Hulusi Behçet in 1937. It is characterized by recurrent inflammatory attacks affecting multiple organs, with uveitis being a significant and severe complication that can lead to blindness. BD typically emerges between the ages of 20 and 30 years, with a higher prevalence in males and rare occurrences in children. The prevalence and severity of BD and its ocular symptoms tend to diminish with age. In Turkey, BD is a leading cause of noninfectious uveitis, and its prevalence varies across different regions. Ocular involvement, seen in up to 90% of BD patients, often appears 2–4 years after disease onset and may be the initial sign in 10%–20% of cases. BD uveitis is characterized by recurrent nongranulomatous panuveitis and retinal vasculitis, typically affecting both eyes. Diagnostic tools such as fluorescein angiography (FA), optical coherence tomography (OCT), and laser flare photometry (LFP) are essential for monitoring disease activity and guiding treatment. FA is crucial for identifying occlusive and leaky vasculitis, while OCT helps in detecting macular complications and visualizing retinal infiltrates and their sequelae. LFP quantitatively evaluates intraocular inflammation. Recognizing the ocular manifestations of BD early is vital for accurate diagnosis and effective management. This review highlights the clinical features, diagnostic tools, and importance of early diagnosis in managing BD uveitis.
- Open Access
- 29 August 2024
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 54 (4) , 198-204
Treatment of Behçet Uveitis in Türkiye
Treatment of Behçet Uveitis in Türkiye - Turkish Journal of Ophthalmology
- 29 August 2024
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 54 (4) , 198-204
Open AccessTreatment of Behçet Uveitis in Türkiye
Treatment of Behçet Uveitis in Türkiye - Turkish Journal of Ophthalmology
- Open Access
- 1 April 2024
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 54 (2) , 112-115
Vitiligo in a Patient Receiving Adalimumab for Idiopathic Uveitis
In recent years, adalimumab has been increasingly used in the chronic treatment of non-infectious uveitis. This case report aimed to describe a drug-induced adverse event in a 34-year-old man who presented with blurred vision and floaters in the right eye and was being treated for intermediate uveitis. The patient had started topical treatment with a diagnosis of uveitis at another center. Best corrected visual acuity at presentation was 0.8 (decimal) in the right eye and 1.0 in the left eye. On examination, the anterior chamber in the right eye was clear, with anterior vitreous cells and mild haze, and snow banking and vitreous opacities in the inferior periphery. Fluorescein angiography (FA) showed hyperfluorescence in the right disc and leakage in the inferior periphery. As the inflammation did not resolve with local treatment, systemic cyclosporine was administered, after which the patient exhibited vomiting and weakness. Cyclosporine was discontinued and adalimumab treatment was started. On examination 5 months later, bilateral vitreous cells and mild vitreous opacity were noted, and FA showed mild leakage in the inferior periphery bilaterally. In addition, a depigmented patchy vitiligo lesion was observed on the chin. Due to the persistence of intraocular inflammation and on the recommendation of the dermatology clinic, adalimumab treatment was continued and topical tacrolimus was started for the lesion. On examination 3 months later, the inflammatory findings had resolved and there was no progression of the vitiligo lesion. The patient's treatment was continued. Taken together with the previous literature findings, no pathology was found in the patient's systemic examination, suggesting that this lesion was a side effect of the treatment. Ophthalmologists should be alert for this side effect in patients receiving adalimumab.
- 1 April 2024
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 54 (2) , 112-115
Open AccessVitiligo in a Patient Receiving Adalimumab for Idiopathic Uveitis
In recent years, adalimumab has been increasingly used in the chronic treatment of non-infectious uveitis. This case report aimed to describe a drug-induced adverse event in a 34-year-old man who presented with blurred vision and floaters in the right eye and was being treated for intermediate uveitis. The patient had started topical treatment with a diagnosis of uveitis at another center. Best corrected visual acuity at presentation was 0.8 (decimal) in the right eye and 1.0 in the left eye. On examination, the anterior chamber in the right eye was clear, with anterior vitreous cells and mild haze, and snow banking and vitreous opacities in the inferior periphery. Fluorescein angiography (FA) showed hyperfluorescence in the right disc and leakage in the inferior periphery. As the inflammation did not resolve with local treatment, systemic cyclosporine was administered, after which the patient exhibited vomiting and weakness. Cyclosporine was discontinued and adalimumab treatment was started. On examination 5 months later, bilateral vitreous cells and mild vitreous opacity were noted, and FA showed mild leakage in the inferior periphery bilaterally. In addition, a depigmented patchy vitiligo lesion was observed on the chin. Due to the persistence of intraocular inflammation and on the recommendation of the dermatology clinic, adalimumab treatment was continued and topical tacrolimus was started for the lesion. On examination 3 months later, the inflammatory findings had resolved and there was no progression of the vitiligo lesion. The patient's treatment was continued. Taken together with the previous literature findings, no pathology was found in the patient's systemic examination, suggesting that this lesion was a side effect of the treatment. Ophthalmologists should be alert for this side effect in patients receiving adalimumab.
- 28 July 2023
- Published by Toplum ve Sosyal Hizmet in Toplum ve Sosyal Hizmet
- Vol. 34 (3) , 527-552
Kronik Üveit Hastalığı Olan Çocuk ve Ailelerinin Hastalık ve Tedavi Sürecine İlişkin Yaşam Deneyimleri
Bu araştırmanın amacı, kronik üveit hastalığı olan çocuklar ve ailelerinin hastalık tanısı, tedavi süreci ve yaşadıkları sorunlar hakkında anlatılarını incelemektir. Nitel yöntemin kullanıldığı bu araştırmanın çalışma grubu, 13 çocuk, 20 aile üyesi ve 13 sağlık profesyonelinden oluşmaktadır. Veriler her üç katılımcı grubuyla yapılan derinlemesine görüşmelerden elde edilmiştir. Verilerin çözümlenmesinde, Maxqda nitel veri analiz programı, teknik olarak da içerik ve tematik analiz tekniği kullanılmıştır. Bulgularda, çocukların eğitimlerinin aksadığı, fiziksel ve psiko-sosyal alanlarda sorunlar yaşadıkları, bir bütün olarak çocuk ve ailesinin iyilik halinin ve yaşam kalitesinin olumsuz etkilendiği öne çıkmıştır. Aile üyelerinin, çocuklarının görme yetisini kaybetme kaygısını yaşadıkları, psikososyal ve ekonomik olarak tükendikleri, bakım ve tedavi olanaklarına erişim, tedaviyi uygulama, toplumsal yaşamdan izole olma alanlarında sorunlar yaşadıkları tespit edilmiştir. Aile üyelerinin tüm bu sorunlarla baş etme stratejilerinde başta kadere sığınma, yaşananları imtihan olarak değerlendirme olmak üzere, sosyoeokonomik seviye, hasta yakınları arasında deneyim paylaşma, aynı gemide olma duygusu ön plana çıkmıştır. Sonuç olarak bir ailede kronik hastalığı olan bir bireyin olması, tüm aile sisteminin, rollerin, dengelerin değişmesine, sosyal ve ekonomik yaşamın derinden etkilenmesine, yani aile yapısının ve sosyal ilişkilerin yeniden yapılanmasına neden olmaktadır.
- 28 July 2023
- Published by Toplum ve Sosyal Hizmet in Toplum ve Sosyal Hizmet
- Vol. 34 (3) , 527-552
Kronik Üveit Hastalığı Olan Çocuk ve Ailelerinin Hastalık ve Tedavi Sürecine İlişkin Yaşam Deneyimleri
Bu araştırmanın amacı, kronik üveit hastalığı olan çocuklar ve ailelerinin hastalık tanısı, tedavi süreci ve yaşadıkları sorunlar hakkında anlatılarını incelemektir. Nitel yöntemin kullanıldığı bu araştırmanın çalışma grubu, 13 çocuk, 20 aile üyesi ve 13 sağlık profesyonelinden oluşmaktadır. Veriler her üç katılımcı grubuyla yapılan derinlemesine görüşmelerden elde edilmiştir. Verilerin çözümlenmesinde, Maxqda nitel veri analiz programı, teknik olarak da içerik ve tematik analiz tekniği kullanılmıştır. Bulgularda, çocukların eğitimlerinin aksadığı, fiziksel ve psiko-sosyal alanlarda sorunlar yaşadıkları, bir bütün olarak çocuk ve ailesinin iyilik halinin ve yaşam kalitesinin olumsuz etkilendiği öne çıkmıştır. Aile üyelerinin, çocuklarının görme yetisini kaybetme kaygısını yaşadıkları, psikososyal ve ekonomik olarak tükendikleri, bakım ve tedavi olanaklarına erişim, tedaviyi uygulama, toplumsal yaşamdan izole olma alanlarında sorunlar yaşadıkları tespit edilmiştir. Aile üyelerinin tüm bu sorunlarla baş etme stratejilerinde başta kadere sığınma, yaşananları imtihan olarak değerlendirme olmak üzere, sosyoeokonomik seviye, hasta yakınları arasında deneyim paylaşma, aynı gemide olma duygusu ön plana çıkmıştır. Sonuç olarak bir ailede kronik hastalığı olan bir bireyin olması, tüm aile sisteminin, rollerin, dengelerin değişmesine, sosyal ve ekonomik yaşamın derinden etkilenmesine, yani aile yapısının ve sosyal ilişkilerin yeniden yapılanmasına neden olmaktadır.